For: | Bonilla H, Quach T, Tiwari A, Bonilla A, Miglis M, Yang P, Eggert L, Sharifi H, Horomanski A, Subramanian A, Smirnoff L, Simpson N, Halawi H, Sum-ping O, Kalinowski A, Patel Z, Shafer R, Geng L. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic.. [DOI: 10.1101/2022.08.03.22278363] [Cited by in F6Publishing: 1] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Zavori L, Molnar T, Varnai R, Kanizsai A, Nagy L, Vadkerti B, Szirmay B, Schwarcz A, Csecsei P. Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome. J Pers Med 2023;13. [PMID: 36836605 DOI: 10.3390/jpm13020371] [Reference Citation Analysis] |
2 | Akanchise T, Angelova A. Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants (Basel) 2023;12. [PMID: 36829952 DOI: 10.3390/antiox12020393] [Reference Citation Analysis] |
3 | Dorri JA, Jason LA. AN EXPLORATORY FACTOR ANALYSIS OF LONG COVID. CAJMHE 2022;3:245-256. [DOI: 10.47316/cajmhe.2022.3.4.04] [Reference Citation Analysis] |
4 | Jason LA, Dorri JA. ME/CFS and Post-Exertional Malaise among Patients with Long COVID. Neurol Int 2022;15:1-11. [PMID: 36648965 DOI: 10.3390/neurolint15010001] [Reference Citation Analysis] |
5 | Goldberg NC, Poirier S, Kanas A, Mccorkell L, Mcginn CA, Re’em Y, Kuehnel K, Muirhead N, Ruschioni T, Taylor-brown S, Jason LA. A new clinical challenge: supporting patients coping with the long-term effects of COVID-19. Fatigue: Biomedicine, Health & Behavior 2022. [DOI: 10.1080/21641846.2022.2128576] [Reference Citation Analysis] |